No results found for "".

Deal Details

C/PIndustryStatusTicker(s)Issuer(s)Size(m)TranchesRegionDate
IGC
HLTH
PRCD
FMEGR
Fresenius Medical Care AG & Co KGaA€1,100
2EMEA
Apr 1, 2025
currency
EUR
size (m)
600.000
maturity
Dec 8, 2028
type
Fixed
tenor
4.000
call
-
registration
Reg S Only
benchmark
Swaps
ranking
Sr. Unsecured
moody's
-
s&p
BBB-
fitch
BBB-
size description
-
re-open/tap
No
ipt
MS+135-140
ipt-pxd
-
guidance
-
spread
98
coupon
3.125%
spread set
-
price
99.55800
yield
3.258%
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
billing & delivering
active leads
-
joint leads
passive leads
-
co-managers
-
coordinating managers
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
billing & delivering
active leads
-
joint leads
passive leads
-
co-managers
-
coordinating managers
-
currency
EUR
size (m)
500.000
maturity
Apr 8, 2032
type
Fixed
tenor
7.000
call
-
registration
Reg S Only
benchmark
Swaps
ranking
Sr. Unsecured
moody's
-
s&p
BBB-
fitch
BBB-
size description
-
re-open/tap
No
ipt
MS+170 a
ipt-pxd
-
guidance
-
spread
138
coupon
3.750%
spread set
-
price
99.37200
yield
3.854%
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
billing & delivering
active leads
-
joint leads
passive leads
-
co-managers
-
coordinating managers
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
billing & delivering
active leads
-
joint leads
passive leads
-
co-managers
-
coordinating managers
-
Tranche Comments
4 yr: Registration: Reg S Only; Comments: EUR600m short 4yr cpn 3.125% at 99.558, yld 3.258%. Spread: MS+98bps. DBR 0 11/15/28 +114.5bp (@ 92.71 Px) / HR 103%. Par Call: 1m. CoC: Yes. Clean-up Call: 80%. Tax Call: Yes. LEI: 549300CP8NY40UP89Q40; 7 yr: Registration: Reg S Only; Comments: EUR500m 7yr cpn 3.75% at 99.372, yld 3.854%. Spread: MS+138bps. DBR 0 02/15/32 +139.9bp (@ 84.65 Px) / HR 106%. Par Call: 3m. CoC: Yes. Clean-up Call: 80%. Tax Call: Yes. LEI: 549300CP8NY40UP89Q40;
Use of Proceeds
Refinancing and general corporate purposes

Commentary

Explore all other Commentary & Deal Flow

Deal Flow

Explore all other Commentary & Deal Flow